Ledger.Open graph →
SEC Form D · filed December 3, 2024

Manifold Biotechnologies, Inc

Offering
$32.8M
Sold
$32.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Steven E. Heuck · Boston, MAExec · DirectorJory Bell · Boston, MADirectorGleb Kuznetsov · Boston, MAExec · DirectorJeff Huber · Boston, MADirectorPierce Ogden · Boston, MAExec · DirectorSteven J. Kafka · Boston, MADirectorSteven Holtzman · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗